TY - JOUR
T1 - Axonal polyneuropathy after acute dimethylamine borane intoxication
AU - Kuo, Hung Chou
AU - Huang, Chin Chang
AU - Chu, Chun Che
AU - Chu, Nai Shin
PY - 2006
Y1 - 2006
N2 - Objective: To study a patient with axonal polyneuropathy due to acute dimethylamine borane (DMAB) intoxication. Patient: Confusion and drowsiness in the acute stage, followed by cognitive impairments and polyneuropathy, are reported in a chemical factory worker after acute exposure to DMAB. Results: Nerve conduction studies indicated axonal polyneuropathy, particularly in the motor nerves. Sural nerve biopsy studies 3 months later revealed an axonal degeneration with a mild decrease of fiber density in the large myelinated fibers. Quantitative sensory testing also disclosed an impairment of pinprick, temperature, and touch sensations. Cutaneous nerve biopsy studies 9 months later demonstrated a moderate loss of epidermal nerves. During the follow-up period of 1.5 years, the clinical features and serial nerve conduction studies showed a steady improvement. Conclusions: Since DMAB is a new product and has been widely used recently in the manufacturing of semiconductors and electronics, we conclude that DMAB intoxication may produce motor-predominant axonal polyneuropathy and that the establishment of a threshold limit value is warranted.
AB - Objective: To study a patient with axonal polyneuropathy due to acute dimethylamine borane (DMAB) intoxication. Patient: Confusion and drowsiness in the acute stage, followed by cognitive impairments and polyneuropathy, are reported in a chemical factory worker after acute exposure to DMAB. Results: Nerve conduction studies indicated axonal polyneuropathy, particularly in the motor nerves. Sural nerve biopsy studies 3 months later revealed an axonal degeneration with a mild decrease of fiber density in the large myelinated fibers. Quantitative sensory testing also disclosed an impairment of pinprick, temperature, and touch sensations. Cutaneous nerve biopsy studies 9 months later demonstrated a moderate loss of epidermal nerves. During the follow-up period of 1.5 years, the clinical features and serial nerve conduction studies showed a steady improvement. Conclusions: Since DMAB is a new product and has been widely used recently in the manufacturing of semiconductors and electronics, we conclude that DMAB intoxication may produce motor-predominant axonal polyneuropathy and that the establishment of a threshold limit value is warranted.
UR - http://www.scopus.com/inward/record.url?scp=33745872966&partnerID=8YFLogxK
U2 - 10.1001/archneur.63.7.1009
DO - 10.1001/archneur.63.7.1009
M3 - 文章
C2 - 16831972
AN - SCOPUS:33745872966
SN - 0003-9942
VL - 63
SP - 1009
EP - 1012
JO - Archives of Neurology
JF - Archives of Neurology
IS - 7
ER -